HOME > TOP STORIES
TOP STORIES
-
BUSINESS Human Judgment Still Key in the AI Era, Pharma Leaders Tell New Recruits
April 2, 2026
-
BUSINESS Pfizer Hails Adult Rollout of Prevenar 20 as “Milestone” for Public Health
April 1, 2026
-
ORGANIZATION JMA’s Ezawa Calls for “National Debate” on Drug Policy
March 31, 2026
-
ACADEMIA Japan Ophthalmology Society Flags Off-Label Concerns Ahead of Upneeq Launch
March 30, 2026
-
BUSINESS Otsuka to Acquire Transcend for US$700 Million, Snags PTSD Candidate
March 30, 2026
-
REGULATORY Japan Ranks 9th Among 10 in AI Analysis of EFPIA Pharma Strategy Report
March 27, 2026
-
BUSINESS Takeda Unveils Annual 200 Billion Yen Cost Savings by FY2028
March 26, 2026
-
REGULATORY Pharma Urges Govt Support as Iran War Shows Early Impact on Supply Chains
March 25, 2026
-
REGULATORY Japan OKs Bayer’s MRI Agent, Haihe’s PI3Kα Med, Enhertu’s Tumor-Agnostic Use, and More
March 24, 2026
-
BUSINESS Novo Japan Logs 5.4% Growth in 2025, Sees Wegovy Powering Push for Double-Digit Goal
March 23, 2026
-
BUSINESS Gilead’s Japan Revenue Up 15% in 2025 as Trodelvy Gains Traction
March 19, 2026
-
BUSINESS Incyte Looks to More Than Double International Business by 2030: CEO
March 18, 2026
-
REGULATORY Japan Sets Up Radiopharma Discovery Hub in Fukushima, Targets Rare Cancers
March 18, 2026
-
BUSINESS BMS Japan “On Track” to Double Sales by 2032 as Launch Wave Nears
March 17, 2026
-
BUSINESS SSP Appoints Yoko Motoshima as New President
March 16, 2026
-
BUSINESS PMP Returns Slam Drug Makers' Leading Products, Prazaxa Cut 45%: Jiho Poll
March 13, 2026
-
BUSINESS Lilly to Invest Additional 20 Billion Yen in Japan's Seishin Plant
March 13, 2026
-
REGULATORY Chuikyo OKs Listing of J&J’s Rybrofaz, Peak Sales Seen at 43.8 Billion Yen
March 12, 2026
-
REGULATORY Truqap Price Cut Set at 10.7% from June under CEA Scheme
March 12, 2026
-
ACADEMIA CAR-T Reimbursement Insufficient, Kyoto University Hospital Chief Warns
March 11, 2026
ページ
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
